If I remember correct, at the ODAC meeting, panelists asked why patients on tivo started dying at about 5 months (referring to the waterfall chart) and AVEO couldn't really answer. I think it was the East Indian panelist who brought it up. I think the timing of their deaths was an issue as well esp when you consider the drug latent effects. Again this is all going by memory.
That's great news if it's true. I don't mean to be skeptical. Another poster posted last week that he spoke to IR and said a PR was forthcoming, which turned out to be false. Can you provide the name of the IR person and time/date that she disclosed this to you? Was this an in-house or external IR person? Whether this is true of not, AVEO should provide shareholders with an update after the disastrous ODAC meeting.
How much of a risk is this? Chances of SEC investigation as well. How common and serious is this? Lawyers will be benefiting by far the most in this. Shareholders will get pennies on the dollar if anything. All company has to do is fire the ceo, cmo, Dr. Motzer, and others directly responsible.
Thanks. I was just about to ask about the other poster who posted a couple of days ago that he called IR and they told him a NR is forthcoming. The sooner the company can inform shareholders the better.
Aveo mgmt. screwed up big time. However, IMO suing is NOT the way to go. Only lawyers will mostly benefit.
Aveo share price may creep up over the next while for various reasons but it going up due to a possible FDA approval in July is definitely not one of the reasons.
If you are serious, click on my profile and see all my Aveo posts. You will see that I am for real.
Everything I have read, heard and watched. Have you read FDA's briefing doc, Aveo's briefing doc, watched the ODAC webcast, numerous Aveo articles since the ODAC disaster, etc.? I still own aveo shares and I would love nothing more than FDA doing a 360 and approving TiVo in July. The chances of them doing that is less than 1%.
"I would not be surprised to see AVEO passing FDA" Crazy. FDA will never approve in July.
"I could be way off of course" Way off course.
I will certainly take $4, which is a ~60% premium right now. I think a lot of shareholders will. I would be happy with $6 but a 140% is unlikely. How many transactions have you seen at 140% premium?
I selected $4 per share because most current shareholders would be happy with $4. It could be $3, $3.50, $4.50, etc. If it is less than $4, Astellas potential discount is greater than 98% and if it is more than $4, potential discount is less than 98%. These are rough numbers give or take.
"I don't think the board will fire the CEO because the CEO is also on the board. "
That would be incorrect. Happens all the time.